Search research articles
Contact Us
Filters
Showing results (141-150 of 208) with videos related to
Page
of 21
Sort By:
The Journal of Biological Chemistry
|
April 19, 2024
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis
Jessica F Calver, Nimesh R Parmar, Gemma Harris, et al.
The Lancet. Respiratory Medicine
|
March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
R Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 2, 2017
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
R Gisli Jenkins, Bethany B Moore, Rachel C Chambers, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 1, 2026
Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD Research
Jeffrey M Sturek, John S Kim, Anna Podolanczuk, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 10, 2019
Clinical quantification of the integrin αvβ6 by [<sup>18</sup>F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
Pauline T Lukey, Christopher Coello, Roger Gunn, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Waldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
Respiratory Research
|
July 14, 2019
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
Louise A Organ, Anne-Marie R Duggan, Eunice Oballa, et al.
Thorax
|
June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohorts
Jannie M B Sand, Peder Frederiksen, Alison E John, et al.
Respirology (Carlton, Vic.)
|
September 29, 2022
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study
Timothy J W Dawes, Colm McCabe, Konstantinos Dimopoulos, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial
Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 208) with videos related to
Sort By:
Page
of 21
The Journal of Biological Chemistry
|
April 19, 2024
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis
Jessica F Calver, Nimesh R Parmar, Gemma Harris, et al.
The Lancet. Respiratory Medicine
|
March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
R Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 2, 2017
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
R Gisli Jenkins, Bethany B Moore, Rachel C Chambers, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 1, 2026
Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD Research
Jeffrey M Sturek, John S Kim, Anna Podolanczuk, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 10, 2019
Clinical quantification of the integrin αvβ6 by [<sup>18</sup>F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
Pauline T Lukey, Christopher Coello, Roger Gunn, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Waldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
Respiratory Research
|
July 14, 2019
Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort
Louise A Organ, Anne-Marie R Duggan, Eunice Oballa, et al.
Thorax
|
June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohorts
Jannie M B Sand, Peder Frederiksen, Alison E John, et al.
Respirology (Carlton, Vic.)
|
September 29, 2022
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study
Timothy J W Dawes, Colm McCabe, Konstantinos Dimopoulos, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial
Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Page
of 21